Two days after
assuming control of VPL Medical
, the Redwood Receiver shut it down.

Jason Cardiff was furious, prompting a twenty-eight page rage filing demanding removal of the Receiver.

Spoiler alert: Cardiff was denied.

We’ve previously covered
Cardiff’s VPL Medical scheme
, so I won’t go to deep into it again here.

At issue was a July 14th deadline, requiring VPL Medical to supply the U.S. Department of Health & Human Services with
two million
COVID-19 masks.

Following a “surprise visit” to VPL Medical’s manufacturing facilities, the Redwood Receiver concluded the company wouldn’t be able to meet its contractual obligations.

VPL has no more than 1 functioning manufacturing machine, which is old and is not functioning well.

That machine is not capable of manufacturing more than 8,000 to 10,000 masks during any given 8- hour shift.

Three of the other machines are used machinery, lacking key parts, and are non-functional.

The Receiver also relied on a statement from Matthew Peters, VPL’s primary investor, confirming

VPL would not be ready to produce 2 million FDA-compliant masks by the HHS contract deadline.

Jason Cardiff argues the Receiver’s decision was based on the “false claim” that there
‘were not enough production lines available to manufacture masks.’

Simply stated, the Receiver has created a double bind for VPL; that is, you need to meet the HHS deadlines, but don’t provide the funds to pay VPL’s Engineer and fund workers to operate the production lines.

In an attempt to circumvent the court order, Cardiff threw money at the FTC.

VPL and Jason Cardiff made offers to the FTC to settle the case.

The offers are far more than the FTC would get if they destroy VPL.

The FTC however suspected Cardiff wasn’t good for the money, and demanded settlement upfront.

Cardiff took this request personally, claiming

the FTC’s inability to see that some risk might be necessary to fund a settlement illustrates the inflexible attitude of agency officials who are not concerned about the constituency they purportedly serve.

He even went so far as to frame the FTC as standing in the way of
‘HHS’s ability to protect the public from the hazards of the Coronavirus.’

The court rejected Cardiff’s arguments, falling back on the reasoning the VPL Medical preliminary injunction was granted.

Reminiscent of their arguments against the Court’s July 7 Preliminary Injunction, Cardiff and VPL have not provided a legal basis on which to remove the Receiver.

The Receiver has been ordered to “[c]onserve, hold, manage, and prevent the loss of all VPL Assets, and perform all acts necessary or advisable to preserve the value of those Assets.”

Based on the information before the Receiver, the Receiver did not clearly violate its fiduciary duty or its Court-ordered obligation to prevent loss of VPL Assets by spending money to fulfill a contract that appeared to be doomed to fail.

Moreover, removing the Receiver at this stage would cause the estate irre

🤖 Quick Answer

What led to the shutdown of VPL Medical by the Redwood Receiver?
Following a surprise inspection of VPL Medical's facilities, the Redwood Receiver determined the company could not meet its contractual obligation to supply two million COVID-19 masks to the U.S. Department of Health & Human Services by the July 14th deadline. The facility possessed only one non-functional manufacturing machine incapable of meeting production requirements.

Why did Jason Cardiff file a legal complaint against the Receiver?
Jason Cardiff filed a twenty-eight page motion demanding the Receiver's removal, expressing significant displeasure over the shutdown decision. However, the court ultimately denied Cardiff's request for removal, upholding the Receiver's determination that VPL Medical could not fulfill its contractual obligations.

🔗 Related Articles

- Details of Neil De Waal’s GSPartners fraud arrest
- BitConnect’s Craig Grant on the run from US authorities
- 42 BTC returned by Finalmente Global, 864 BTC “irrecoverable”
- Akashx: My Daily Choice’s “social trading” securities fraud
- Essens Review v2: Tons of products, no retail focus